Contract Research Organization (CROs) Services Market USD 166.80 Billion By 2032, CAGR 9.4%

Contract Research Organization (CROs) Services Market Size Worth USD 166.80 Billion By 2032 | CAGR: 9.4%

The Contract Research Organization (CROs) Services market size is expected to reach USD 166.80 Billion by 2032, according to a new study by Polaris Market Research. The report “Contract Research Organization (CROs) Services Market Share, Size, Trends, Industry Analysis Report, By Service Type; By Therapeutic Area; By End-Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Contract Research Organization (CRO) services market has witnessed significant growth in technological advancements, transforming the landscape of pharmaceutical and biotechnology research. Advanced data analytics, artificial intelligence, and machine learning algorithms are being integrated into different stages of clinical trials, providing unprecedented insights into patient data, speeding up recruitment processes, and optimizing trial design. The use of electronic data capture (EDC) systems has transformed data management, allowing for real-time access and analysis of clinical trial data while maintaining data integrity and security. Furthermore, the integration of wearable devices and mobile health (mHealth) technologies has enabled remote patient monitoring, allowing for continuous and real-world insights into patient health. Contract Research Organizations (CROs) are outsourcing companies that specialize in performing specific and targeted research and development (R&D) tasks for the pharmaceutical or biotechnology industries.

The surging inclination towards personalized medicine, as well as the evolution of biologics spurring market growth. Furthermore, advances in genomics and molecular biology are facilitating the development of personalized therapies tailored to individual genetic profiles. Contract Research Organizations (CROs) play a crucial role in directing biomarker-driven clinical trials to identify patient subpopulations with the best responses to specific treatments, thereby optimizing the drug development process. Furthermore, the development of biologics such as monoclonal antibodies, cell therapies, and gene therapies is facilitating the treatment of complex diseases. There is a high demand for contract research organizations with biologics expertise to assist in the development, manufacturing, and testing of these ground-breaking therapies. Similarly, CROs that focus on personalized medicine and biologics provide critical regulatory assistance, guiding clients through the unique challenges and prerequisites associated with these advanced treatments.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Many companies in the biopharmaceutical, pharmaceutical, and medical device industries invest significant resources in the development of new medications and technologies. Typically, sponsors delegate therapeutic and other product development responsibilities to external service providers. This approach allows them to adopt a more flexible cost structure while also eliminating the need to maintain redundant development capabilities on a global scale. This trend indicates that pharmaceutical companies are raising their research and development (R&D) efficiencies through collaborative R&D efforts. The pharmaceutical R&D sector is changing as companies embrace remote work in an effort to make trial endpoints more patient-centric and responsive.

Contract Research Organization (CROs) Services Market Report Highlights

  • The clinical research services segment held the largest market share in 2023 due to a major factor along with a surging number of clinical trials.
  • The oncology segment dominated the market in 2023, owing to factors like the continuously rising number of clinical trials against indications of oncology.
  • Asia-Pacific has witnessed the fastest growth in the contract research organization (CROs) services market due to the improvements in healthcare infrastructure, quickly evolving regulatory environment, and access to expertise.
  • The key market players include AccuLab Life Sciences, Caidya, Charles River Laboratories, CTI Clinical Trial & Consulting, IQVIA Inc., KCR S.A., Labcorp Drug Development, Lexitas, Medpace, Parexel International (MA) Corporation, Pharmaron, Syneos Health, TFS HealthScience, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the contract research organization (CROs) services market report based on service type, therapeutic area, end-use, and country:

Contract Research Organization (CROs) Services, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Clinical Research Services
  • Phase I Clinical Research Services
  • Phase II Clinical Research Services
  • Phase III Clinical Research Services
  • Phase IV Clinical Research Services
  • Early-Phase Development Services
  • Discovery Studies
  • Chemistry, Manufacturing, & Control (CMC)
  • Preclinical Services
  • Pharmacokinetics/Pharmacodynamics (PK/PD)
  • Toxicology Testing Services
  • Other Preclinical Services
  • Laboratory Services
  • Bioanalytical Testing Services
  • Analytical Testing Services
  • Physical Characterization
  • Raw Material Testing
  • Batch-Release Testing
  • Stability Testing
  • Other Analytical Testing Services
  • Consulting Services

Contract Research Organization (CROs) Services, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • CNS Disorder
  • Cardiology
  • Infectious Disease
  • Metabolic Disorder
  • Renal/Nephrology
  • Others

Contract Research Organization (CROs) Services, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharmaceutical & Biopharmaceutical
  • Medical Device Companies
  • Academic and Research Institutes
  • Others

Contract Research Organization (CROs) Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Contract Research Organization (CROs) Services Market Report Scope

Report Attributes


Market size value in 2024

USD 81.00 billion

Revenue forecast in 2032

USD 166.80 billion


9.4% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments Covered

By Service Type, By Therapeutic Area, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation

For Specific Research Requirements

Request for Customized Report